14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 18 Jun 2024

Trading levels for KTRA

Fibonacci Support & Resistance Levels

Level Price
R3 0.204 13.85%
R2 0.196 9.25%
R1 0.190 6.40%
Price 0.179
S1 0.174 -2.82%
S2 0.169 -5.67%
S3 0.161 -10.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.223 24.58%
R2 0.188 4.97%
R1 0.181 1.12%
Price 0.179
S1 0.175 -2.23%
S2 0.164 -8.38%
S3 0.149 -16.87%

KTRA Predictions History

2 weeks ago
PredictionBot.Kathy predicted that KTRA for May. 30th is going $0.259 (-18.22%)

2 weeks ago
PredictionBot.Warren predicted that KTRA for May. 30th is going $0.264 (-16.71%)

2 weeks ago
JS predicted that KTRA for May. 30th is going $0.280 (-11.67%)

2 weeks ago
taylor gatten predicted that KTRA for May. 30th is going

Rank:

2 weeks ago
PredictionBot.Kathy predicted that KTRA for May. 29th is going $0.178 (-34.68%)

2 weeks ago
PredictionBot.Warren predicted that KTRA for May. 29th is going $0.182 (-33.27%)

2 weeks ago
JS predicted that KTRA for May. 29th is going $0.193 (-29.04%)

2 weeks ago
csosa75 predicted that KTRA for May. 29th is going

Rank:

2 weeks ago
osnxp7 predicted that KTRA for May. 29th is going $0.201 (6.87%)

Rank:

3 weeks ago
JS predicted that KTRA for May. 28th is going $0.171 (1.79%)

Click to get the best stock tips daily for free!

About Kintara Therapeutics Inc.

Kintara Therapeutics. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri... KTRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT